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Background: Deep venous thrombosis (DVT) of the lower extremities is a common
cause of morbidity and mortality among neurologically injured patients. The data on
incidence and prevalence rates of DVT among high risk neurologic populations is
scarce. The available literature focuses largely on patients admitted to a medical or
surgical intensive care unit with very limited information on patients in neuro-intensive
care units (NICU). The aim of the present study is to assess the incidence and prevalence of deep vein thrombosis among patients admitted with acute neurologic injury.
Methods: We conducted a retrospective review of ultrasound records of 2,644 patients
admitted to NICU, stroke or INICU at a university hospital over a 13-month period. We
included all patients who underwent routine lower extremity ultrasound on admission
and weekly. Data was abstracted and analyzed to assess the prevalence of DVT in this
period. We excluded patients presenting with superficial vein thrombosis, hematoma
and chronic venous scarring.
Results: Among the 2,644 patients studied, 161 were diagnosed with DVT. The overall
prevalence of DVT was 6.1%. Of the 161 cases of DVT; 87 (54%) were diagnosed with
DVT at the time of admission. In our sample, the rate of DVT present on admission was
3.3%. There were 74 cases of hospital-acquired DVT, yielding an incidence of 2.8%.
Patients with DVT at the time of admission were largely Caucasian males with mean
age 72 and mean SAPS II score of 34.2, ranging between 13 and 71.
Conclusions: Patients admitted to a neuro ICU are at high risk for having DVT present
on admission and for acquiring DVT during their hospitalization. Further research
is needed to understand the risk profile of patients with acute neurological injury.
Asymptomatic screening of high risk patients on admission to a neurologic ICU, stroke
unit, or intermediate care unit will identify a significant number of cases of DVT present
of admission that might otherwise be misidentified as hospital acquired cases.

INTRODUCTION
Venous thromboembolism (VTE) including deep vein thrombosis (DVT) and pulmonary
embolism (PE) is a significant health complication for critically ill hospitalized patients.
DVT is a preventable health problem associated with several adverse outcomes
including death. Among neurosurgical patients, the risk of DVT without prophylaxis
is 22-35%, while spinal cord injury patients who do not receive prophylaxis have rates
ranging from 50-85%.1 It is tempting to assume that previously healthy, acutely injured
neuroscience patients who are diagnosed with DVT represent hospital-acquired
disease; these patients generally do not have identifiable risk factors for DVT prior to
the onset of acute illness. However, there is no data to support these assumptions.
Intensive care unit patients represent a heterogeneous population. The available
literature describes the prevalence, incidence and risk factors associated with the
development of DVT among patients admitted to medical and surgical intensive care
units and following trauma, neurosurgery, or spinal cord injury.1-7 An estimated 10-30%
of medical and surgical intensive care unit patients are known to develop DVT within
the first week of admission. However, there is limited to no data about the DVT risk
profile of patients admitted to a neuro-intensive care unit (NICU). The aim of the
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Table 1. Prevalence and Incidence of DVT
among acute neuroscience patients
N

2644

Prevalence

161 (6.1%)

Incidence

74 (2.9%)

N

161

DVT present on admission

87 (54.0%)

DVT developed in hospital

74 (45.9%)

Table 2. Characteristics of patients with DVT
at the time of admission

Age (yrs)
Sex

Race

SAPS II
score

N

87

Mean ± SD

72±12.0

Range

29-94

Males

52.7%

Females

47.3%

Caucasian

72.9%

African-American

12.2%

Others

1.5%

Mean ± SD

34.2±14.8

Range

13-71

present study is to assess the incidence
and prevalence of deep vein thrombosis
among patients admitted with acute
neurologic injury.

METHODS
In this retrospective study, data on all
patients admitted to Neuro ICU, stroke or
INICU of a tertiary care teaching hospital
between December 2013 and January
2014 were included. Patients presenting
with superficial vein thrombosis, hematoma
and chronic venous scarring were excluded
from the analysis. Our institution routinely
conducts ultrasound screening within 24
hours of admission and weekly thereafter
in high risk neurologically injured patients.

DVT Prevalence in the ICU

A retrospective review of ultrasound records
was conducted to identify patients with DVT.
To estimate the prevalence of DVT;
number of patients presenting with DVT,
identified through ultrasound screening
within 24 hours of admission; patients
with a history of chronic DVT and patients
who developed DVT during their stay in
the hospital identified through weekly
ultrasound screening were computed.
We estimated the overall prevalence of
DVT by calculating the rate of DVT in our
study population. We also describe the
rate of DVT present on admission and
the incidence of hospital-acquired DVT.
Various demographic characteristics,
such as patient’s age, sex, race were
abstracted and health evaluation (SAPS
II) score was calculated to describe the
population presenting with DVT at the
time of admission. Continuous data
are expressed as mean with standard
deviation and range. Categorical data
are summarized to present counts and
percentages.

RESULTS
A total of 2,644 ultrasound records were
reviewed. Over a period of one year; the
prevalence of DVT among neuro ICU
patients was found to be 6.1%, a total of
161 cases. Of the 161 patients diagnosed
with DVT, 87 (54.0%) presented with
DVT at the time of admission. Patients
developed DVT during their stay in the
hospital in 74/161 (46%) of all the cases
diagnosed with DVT.
The study found that 3.3% of the 2,644
patients admitted to our acute neuroscience units between 2013-2014 presented

with DVT at the time of admission. After
excluding patients with a known case
of DVT on admission, the population
at risk of developing DVT in our sample
comprised of 2,556 cases. The number
of cases that developed DVT during their
stay in the intensive care unit was 74 of
2,556 patients, resulting in an incidence
rate of 2.9% among neuro ICU patients.
(Table 1)
Analysis of various demographic characteristics revealed that majority of
patients who presented with DVT on
admission were Caucasian males with
a mean age 72. The mean SAPS II score
for these cases was found to be 34.2.
(Table 2)

CONCLUSION
There are several studies assessing
the incidence and prevalence of DVT
among critically ill surgical and medical
ICU patients. Our study is among the
few describing the prevalence of DVT
among patients with acute neurologic
injury. The prevalence of DVT among
patients admitted to a neuro ICU is
relatively high. Slightly over half of the
cases diagnosed with DVT presented
with this problem at the time of admission to the intensive care unit. Without
timely admission screening, these cases
will be incorrectly identified as hospitalacquired cases. Current best-practices
such as early mobilization, mechanical
compression devices, and chemoprophylaxis, remain important. These data
suggest, however, that many patients
acquire DVT within hours of their acute
neurologic injury. Inpatient DVT risk
prevention strategies are unlikely to

impact the diagnosis of DVT for these
patients. These patients may benefit
from ultra-early, pre-hospital or emergency department-based interventions.
In addition to the findings reported
herein, further research is needed to
understand the risk factors for ultra-early
DVT and hospital acquired DVT within
the high-risk population of patients with
acute neurological injury.
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